matrix metalloproteinase inhibitors

Preferred Label : matrix metalloproteinase inhibitors;

MeSH definition : Compounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES.;

MeSH synonym : inhibitors, matrix metalloproteinase; metalloproteinase inhibitors, matrix; MMP inhibitors; inhibitors, MMP; Matrix Metalloproteinase Inhibitor; Inhibitor, Matrix Metalloproteinase; Metalloproteinase Inhibitor, Matrix; MMP Inhibitor; Inhibitor, MMP;

Related MeSH term : collagenase inhibitors; stromelysin inhibitors; gelatinase inhibitors; Inhibitors, Stromelysin; Inhibitors, Gelatinase; Inhibitors, Collagenase; Gelatinase Inhibitor; Inhibitor, Gelatinase; Collagenase Inhibitor; Inhibitor, Collagenase;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D061965;

UMLS CUI

C1513016;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Matrix Metalloproteinase Inhibitor [NCIt concept]
Indexing information
- 1,3-diacetoxytetradeca-6,12-dien-8,10-diyne [MeSH Supplementary Concept]
- 1-ethyl-3-(4-(4-((thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl)urea [MeSH Supplementary Concept]
- 2-((2,3-dihydroxypropyl)((4-methoxyphenyl)sulfonyl)amino)-N-hydroxyacetamide [MeSH Supplementary Concept]
- 2-(3-(3,4-bis(benzyloxy)phenyl)acryloyloxy)-3-(3,4-dimethoxyphenyl)propanoic acid [MeSH Supplementary Concept]
- 4-(4-((thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl ethylcarbamate [MeSH Supplementary Concept]
- AZD6605 [MeSH Supplementary Concept]
- N-feruloyl-3-methyldopamine [MeSH Supplementary Concept]
- N-hydroxy-2-((4-phenylphenyl)sulfonylpropan-2-yloxyamino)acetamide [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- collagenases [MeSH Descriptor]
- matrix metalloproteinase 1 [MeSH Descriptor]
- matrix metalloproteinase 10 [MeSH Descriptor]
- matrix metalloproteinase 11 [MeSH Descriptor]
- matrix metalloproteinase 12 [MeSH Descriptor]
- matrix metalloproteinase 13 [MeSH Descriptor]
- matrix metalloproteinase 14 [MeSH Descriptor]
- matrix metalloproteinase 15 [MeSH Descriptor]
- matrix metalloproteinase 16 [MeSH Descriptor]
- matrix metalloproteinase 17 [MeSH Descriptor]
- matrix metalloproteinase 2 [MeSH Descriptor]
- matrix metalloproteinase 20 [MeSH Descriptor]
- matrix metalloproteinase 3 [MeSH Descriptor]
- matrix metalloproteinase 7 [MeSH Descriptor]
- matrix metalloproteinase 8 [MeSH Descriptor]
- matrix metalloproteinase 9 [MeSH Descriptor]
- matrix metalloproteinases [MeSH Descriptor]
- matrix metalloproteinases, membrane-associated [MeSH Descriptor]
Record concept(s)
- collagenase inhibitors [MeSH concept]
- gelatinase inhibitors [MeSH concept]
- matrix metalloproteinase inhibitors [MeSH concept]
- stromelysin inhibitors [MeSH concept]
See also inter- (CISMeF)
- Metalloproteinase Inhibitor 1 [NCIt concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- (R)-2-(4'-bromo-biphenyl-4-sulfonyl-amino)-3-methyl-butyric acid [MeSH Supplementary Concept]
- (diethyl((methylsulfinyl)methyl)phosphonate)(dimethylmalonato)platinum(II) [MeSH Supplementary Concept]
- 1-benzyl-4-(4-(4-chlorophenoxy)benzenesulfonyl)piperidine-4-carboxylic acid [MeSH Supplementary Concept]
- 1-cyclopropyl-N-hydroxy-4-(4-(4-(trifluoromethoxy)phenoxy)phenylsulfonyl)piperidine-4-carboxamide [MeSH Supplementary Concept]
- 2'-fluoro-6,7-methylenedioxy-2-phenyl-4-quinolone [MeSH Supplementary Concept]
- 2-((4-biphenylsulfonyl)amino)-3-phenylpropionic acid [MeSH Supplementary Concept]
- 2-(4'-methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid [MeSH Supplementary Concept]
- 2-(4-(but-2-ynyloxy)phenylsulfonamido)-3-(1-(4-methoxybenzyl)-1H-indol-3-yl)propanoic acid [MeSH Supplementary Concept]
- 2-(4-hydroxy-3-methyl-2-butenyl)hydroquinone [MeSH Supplementary Concept]
- 2-(8-(methoxycarbonylamino)dibenzo(b,d)furan-3-sulfonamido)-3-methylbutanoic acid [MeSH Supplementary Concept]
- 2-(biphenyl-4-ylsulfonyl)-1,2,3,4-tetrahydroisoquinolin-3-carboxylic acid [MeSH Supplementary Concept]
- 3,4,5-trihydroxybenzaldehyde [MeSH Supplementary Concept]
- 3-(((2,2-dimethyl-1-(((2-methoxy-1-phenylethyl)amino)carbonyl)propyl)amino)carbonyl)-6-(3-methyl-4-phenylphenyl)hexanoic acid [MeSH Supplementary Concept]
- 3-((benzyl)(methylaminocarbonyl)methylaminocarbonyl)N-hydroxy-5-methylhexanamide [MeSH Supplementary Concept]
- 3-methyl-2-(4-(3-p-tolyl(1,2,4)oxadiazol-5-yl)benzenesulfonylamino)butyric acid [MeSH Supplementary Concept]
- 4-(4-(4-fluorophenoxy)benzenesulfonylamino)tetrahydropyran-4-carboxylic acid hydroxyamide [MeSH Supplementary Concept]
- 4-(carboxy-(5-(4'-ethoxyphenyl)thiophene-2-sulfonylamino)methyl)piperidine-1-carboxylic acid isopropyl ester [MeSH Supplementary Concept]
- 4-des-dimethylaminotetracycline [MeSH Supplementary Concept]
- 4-methyl-1-((5-((3-oxo-3,4-dihydro-2H-benzo(1,4)oxazin-6-ylmethyl)carbamoyl)pyrazolo(1,5-a)pyrimidine-7-carbonyl)amino)indan-5-carboxylic acid [MeSH Supplementary Concept]
- 5-aza-6-cyclohexylmethyl-3-cyclohexylpropyl-4,7-dioxo-7-(phenylethylamino)heptanohydroxamic acid [MeSH Supplementary Concept]
- 5-aza-6-cyclohexylmethyl-4,7-dioxo-7-(phenylethylamino)-3-phenylpropylheptanohydroxamic acid [MeSH Supplementary Concept]
- 5-methyl-2-(4-methylphenyl)-1H-benzimidazole [MeSH Supplementary Concept]
- 6-(4-(4-imidazol-1-ylphenoxy)benzenesulfonyl)-4,5,6,7-tetrahydrofuro(2,3-c)pyridine-5-carboxylic acid [MeSH Supplementary Concept]
- AZD3342 [MeSH Supplementary Concept]
- BB87 collagenase inhibitor [MeSH Supplementary Concept]
- CGS 27023 [MeSH Supplementary Concept]
- CH1766 [MeSH Supplementary Concept]
- CH6631 [MeSH Supplementary Concept]
- CL82198 [MeSH Supplementary Concept]
- CT 1418 [MeSH Supplementary Concept]
- L 758354 [MeSH Supplementary Concept]
- LY52 compound [MeSH Supplementary Concept]
- MAG 283 [MeSH Supplementary Concept]
- N(4)-(2,2-dimethyl-1-methylcarbamoylpropyl)-N(1)-hydroxy-2-hydroxymethyl-3-(4-methoxyphenyl)succinamide [MeSH Supplementary Concept]
- N(4)-(2,2-dimethyl-1-methylcarbamoylpropyl)-N(1)-hydroxy-2-hydroxymethyl-3-phenylsuccinamide [MeSH Supplementary Concept]
- N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide [MeSH Supplementary Concept]
- N-(2-isobutyl-3-(N'-hydroxycarbonylamido)propanoyl)-O-methyltyrosinemethylamide [MeSH Supplementary Concept]
- N-(3-N-(benzyloxycarbonyl)amino-1-carboxypropyl)leucyl-O-methyltyrosine N-methylamide [MeSH Supplementary Concept]
- N-alpha-(4-(2-phenyl-2H- tetrazole-5-yl) phenyl sulfonyl)-D-tryptophan [MeSH Supplementary Concept]
- N-benzyloxycarbonyl-prolyl-alanyl-3-amino-2-oxopropyl-leucyl-alanyl-glycine ethyl ester [MeSH Supplementary Concept]
- N-biphenylsulfonylphenylalanine hydroxamic acid [MeSH Supplementary Concept]
- N-hydroxy-1-(2-methoxyethyl)-4-((4-(4-(trifluoromethoxy)phenoxy)phenyl)sulfonyl)piperidine-4-carboxamide [MeSH Supplementary Concept]
- N-hydroxy-2-(((4'-methoxyphenyl)sulfonyl)benzylamino)-3-methylbutanamide [MeSH Supplementary Concept]
- N-hydroxy-2-(4-methoxybenzenesulfonyl)-2-methyl-3-(4-(2-piperidin-1-ylethoxy)phenyl)propionamide [MeSH Supplementary Concept]
- N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamide [MeSH Supplementary Concept]
- N-hydroxy-4-((4-(4-(trifluoromethyl)phenoxy)phenyl)sulfonyl)tetrahydro-2H-pyran-4-carboxamide [MeSH Supplementary Concept]
- N-hydroxy-4-((4-(phenylthio)phenyl)sulfonyl)-1-(2-propynyl)-4-piperidinecarboxamide [MeSH Supplementary Concept]
- N-hydroxy-4-((4--methoxyphenyl)sulfonyl)-2,2-dimethylhexahydro-1,4-thiazepine-3-carboxamide 1,1-dioxide [MeSH Supplementary Concept]
- N-hydroxy-4-((4-methoxyphenyl)sulfonyl)-2,2-dimethylhexahydro-1,4-thiazepine-3-carboxamide [MeSH Supplementary Concept]
- N-hydroxy-5-ethoxymethyloxy-2-methyl-4-(4-phenoxybenzoyl)aminopentanamide [MeSH Supplementary Concept]
- N2-(2-((hydroxycarbamoyl)methyl)-4-methylvaleryl)-N1,3-dimethylvalinamide [MeSH Supplementary Concept]
- OSU8 1 [MeSH Supplementary Concept]
- PD 180557 [MeSH Supplementary Concept]
- PF152 compound [MeSH Supplementary Concept]
- PGE 1132881 [MeSH Supplementary Concept]
- PNU 107859 [MeSH Supplementary Concept]
- PNU 141803 [MeSH Supplementary Concept]
- PNU 142372 [MeSH Supplementary Concept]
- RXP 409 [MeSH Supplementary Concept]
- RXP470.1 peptide [MeSH Supplementary Concept]
- S 3304 [MeSH Supplementary Concept]
- SCH 43534 [MeSH Supplementary Concept]
- SI 27 [MeSH Supplementary Concept]
- SM 7368 [MeSH Supplementary Concept]
- YL 01869P [MeSH Supplementary Concept]
- YLL 224 [MeSH Supplementary Concept]
- cadin-2-en-1-ol-1-glucuronopyranoside [MeSH Supplementary Concept]
- dichloro(diethyl((methylsulfinyl)methyl)phosphonate)platinum(II) [MeSH Supplementary Concept]
- funalenone [MeSH Supplementary Concept]
- matlystatin A [MeSH Supplementary Concept]
- matlystatin B [MeSH Supplementary Concept]
- matlystatin D [MeSH Supplementary Concept]
- matlystatin E [MeSH Supplementary Concept]
- matlystatin F [MeSH Supplementary Concept]
- methyl 6-(benzyloxycarbonylamino)-2-(2-(2,6-dioxo-3-(3,4,5-trimethoxybenzamido)piperidin-1-yl)acetamido)hexanoate [MeSH Supplementary Concept]
- phthaloyl-glycyl(P)-isoleucyl-tryptophyl-benzylamide [MeSH Supplementary Concept]
- prinomastat [MeSH Supplementary Concept]
- ro 26-2812 [MeSH Supplementary Concept]
- ro 32-3555 [MeSH Supplementary Concept]
- saucerneol G [MeSH Supplementary Concept]
- tissue inhibitor of metalloproteinase-1 [MeSH Descriptor]
- tissue inhibitor of metalloproteinase-2 [MeSH Descriptor]
- tissue inhibitor of metalloproteinase-3 [MeSH Descriptor]
- tissue inhibitor of metalloproteinases [MeSH Descriptor]
- triazin 17-2 [MeSH Supplementary Concept]
- zincov [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Matrix Metalloproteinase Inhibitor [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients